Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how

Dual antiplatelet therapy (DAPT) for 6–12 months, followed by lifelong aspirin monotherapy is considered an effective standard therapy for the prevention of thrombo-ischemic events in patients with acute and chronic coronary syndrome (ACS, CCS) undergoing percutaneous coronary intervention (PCI) or...

Descripción completa

Detalles Bibliográficos
Autores principales: Muthspiel, Marie, Kaufmann, Christoph C., Burger, Achim Leo, Panzer, Benjamin, Verheugt, Freek W. A., Huber, Kurt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684463/
https://www.ncbi.nlm.nih.gov/pubmed/36440022
http://dx.doi.org/10.3389/fcvm.2022.1008194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684463/
https://www.ncbi.nlm.nih.gov/pubmed/36440022
http://dx.doi.org/10.3389/fcvm.2022.1008194

Ejemplares similares